Does the media favor VMD or AGL?

In the previous week, Viemed Healthcare and Viemed Healthcare both had 2 articles in the media. Viemed Healthcare's average media sentiment score of 0.61 beat Agilon Health's score of 0.29 indicating that Viemed Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Viemed Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agilon Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to PNTG or VMD?

In the previous week, The Pennant Group had 1 more articles in the media than Viemed Healthcare. MarketBeat recorded 3 mentions for The Pennant Group and 2 mentions for Viemed Healthcare. The Pennant Group's average media sentiment score of 0.91 beat Viemed Healthcare's score of 0.61 indicating that The Pennant Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment The Pennant Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Viemed Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer AMN or VMD?

In the previous week, AMN Healthcare Services had 1 more articles in the media than Viemed Healthcare. MarketBeat recorded 3 mentions for AMN Healthcare Services and 2 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 0.61 beat AMN Healthcare Services' score of 0.46 indicating that Viemed Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Viemed Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, VMD or OMDA?

Viemed Healthcare has higher revenue and earnings than Omada Health. Viemed Healthcare is trading at a lower price-to-earnings ratio than Omada Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Viemed Healthcare $270.28M 1.37 $14.93M $0.36 26.92 Omada Health $260.21M 4.29 -$12.78M $0.05 364.40

Does the media prefer VMD or OMDA?

In the previous week, Omada Health had 10 more articles in the media than Viemed Healthcare. MarketBeat recorded 12 mentions for Omada Health and 2 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 0.61 beat Omada Health's score of 0.44 indicating that Viemed Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Viemed Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Omada Health 1 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor VMD or INNV?

In the previous week, InnovAge had 3 more articles in the media than Viemed Healthcare. MarketBeat recorded 5 mentions for InnovAge and 2 mentions for Viemed Healthcare. InnovAge's average media sentiment score of 0.97 beat Viemed Healthcare's score of 0.61 indicating that InnovAge is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Viemed Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InnovAge 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Viemed Healthcare (VMD) Competitors

$9.69 +0.08 (+0.83%)

Closing price 10/14/2026 04:00 PM Eastern

Extended Trading

$9.64 -0.05 (-0.51%)

As of 06:58 AM Eastern

Compare

VMD vs. AGL, PNTG, AMN, OMDA, and INNV

Should you buy Viemed Healthcare stock or one of its competitors? Viemed Healthcare's main competitors and comparable companies include Agilon Health (AGL), The Pennant Group (PNTG), AMN Healthcare Services (AMN), Omada Health (OMDA), and InnovAge (INNV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Viemed Healthcare compare to Agilon Health?

Viemed Healthcare (NASDAQ:VMD) and Agilon Health (NYSE:AGL) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, risk and profitability.

Viemed Healthcare has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viemed Healthcare	$270.28M	1.37	$14.93M	$0.36	26.92
Agilon Health	$5.93B	0.25	-$391.35M	-$14.27	N/A

In the previous week, Viemed Healthcare and Viemed Healthcare both had 2 articles in the media. Viemed Healthcare's average media sentiment score of 0.61 beat Agilon Health's score of 0.29 indicating that Viemed Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Viemed Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Agilon Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

74.2% of Viemed Healthcare shares are held by institutional investors. 20.6% of Viemed Healthcare shares are held by company insiders. Comparatively, 2.5% of Agilon Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Viemed Healthcare has a beta of 1.04, meaning that its share price is 4% more volatile than the broader market. Comparatively, Agilon Health has a beta of 2.98, meaning that its share price is 198% more volatile than the broader market.

Viemed Healthcare currently has a consensus target price of $14.00, suggesting a potential upside of 44.48%. Agilon Health has a consensus target price of $102.25, suggesting a potential upside of 17.35%. Given Viemed Healthcare's higher probable upside, equities analysts plainly believe Viemed Healthcare is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viemed Healthcare	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25
Agilon Health	2 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.27

Viemed Healthcare has a net margin of 4.81% compared to Agilon Health's net margin of -3.92%. Viemed Healthcare's return on equity of 10.16% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Viemed Healthcare	4.81%	10.16%	7.22%
Agilon Health	-3.92%	-119.38%	-16.85%

Summary

Viemed Healthcare beats Agilon Health on 11 of the 15 factors compared between the two stocks.

How does Viemed Healthcare compare to The Pennant Group?

The Pennant Group (NASDAQ:PNTG) and Viemed Healthcare (NASDAQ:VMD) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

The Pennant Group presently has a consensus price target of $42.00, suggesting a potential upside of 2.89%. Viemed Healthcare has a consensus price target of $14.00, suggesting a potential upside of 44.48%. Given Viemed Healthcare's higher possible upside, analysts plainly believe Viemed Healthcare is more favorable than The Pennant Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
The Pennant Group	0 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.86
Viemed Healthcare	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25

Viemed Healthcare has a net margin of 4.81% compared to The Pennant Group's net margin of 2.93%. The Pennant Group's return on equity of 10.33% beat Viemed Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The Pennant Group	2.93%	10.33%	4.20%
Viemed Healthcare	4.81%	10.16%	7.22%

85.9% of The Pennant Group shares are owned by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are owned by institutional investors. 6.9% of The Pennant Group shares are owned by company insiders. Comparatively, 20.6% of Viemed Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, The Pennant Group had 1 more articles in the media than Viemed Healthcare. MarketBeat recorded 3 mentions for The Pennant Group and 2 mentions for Viemed Healthcare. The Pennant Group's average media sentiment score of 0.91 beat Viemed Healthcare's score of 0.61 indicating that The Pennant Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
The Pennant Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Viemed Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

The Pennant Group has a beta of 1.25, meaning that its share price is 25% more volatile than the broader market. Comparatively, Viemed Healthcare has a beta of 1.04, meaning that its share price is 4% more volatile than the broader market.

The Pennant Group has higher revenue and earnings than Viemed Healthcare. Viemed Healthcare is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The Pennant Group	$947.71M	1.50	$29.58M	$0.90	45.36
Viemed Healthcare	$270.28M	1.37	$14.93M	$0.36	26.92

Summary

The Pennant Group beats Viemed Healthcare on 12 of the 16 factors compared between the two stocks.

How does Viemed Healthcare compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Viemed Healthcare (NASDAQ:VMD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

In the previous week, AMN Healthcare Services had 1 more articles in the media than Viemed Healthcare. MarketBeat recorded 3 mentions for AMN Healthcare Services and 2 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 0.61 beat AMN Healthcare Services' score of 0.46 indicating that Viemed Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Viemed Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AMN Healthcare Services currently has a consensus price target of $36.50, suggesting a potential downside of 3.51%. Viemed Healthcare has a consensus price target of $14.00, suggesting a potential upside of 44.48%. Given Viemed Healthcare's higher probable upside, analysts clearly believe Viemed Healthcare is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Viemed Healthcare	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by company insiders. Comparatively, 20.6% of Viemed Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

AMN Healthcare Services has a beta of 0.4, meaning that its stock price is 60% less volatile than the broader market. Comparatively, Viemed Healthcare has a beta of 1.04, meaning that its stock price is 4% more volatile than the broader market.

Viemed Healthcare has a net margin of 4.81% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat Viemed Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	3.06%	19.92%	5.93%
Viemed Healthcare	4.81%	10.16%	7.22%

Viemed Healthcare has lower revenue, but higher earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.54	-$95.70M	$2.68	14.11
Viemed Healthcare	$270.28M	1.37	$14.93M	$0.36	26.92

Summary

Viemed Healthcare beats AMN Healthcare Services on 9 of the 16 factors compared between the two stocks.

How does Viemed Healthcare compare to Omada Health?

Viemed Healthcare (NASDAQ:VMD) and Omada Health (NASDAQ:OMDA) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, media sentiment and institutional ownership.

Viemed Healthcare has a net margin of 4.81% compared to Omada Health's net margin of 1.39%. Viemed Healthcare's return on equity of 10.16% beat Omada Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Viemed Healthcare	4.81%	10.16%	7.22%
Omada Health	1.39%	2.60%	1.98%

Viemed Healthcare presently has a consensus target price of $14.00, indicating a potential upside of 44.48%. Omada Health has a consensus target price of $26.67, indicating a potential upside of 46.36%. Given Omada Health's stronger consensus rating and higher possible upside, analysts clearly believe Omada Health is more favorable than Viemed Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viemed Healthcare	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25
Omada Health	1 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.80

In the previous week, Omada Health had 10 more articles in the media than Viemed Healthcare. MarketBeat recorded 12 mentions for Omada Health and 2 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 0.61 beat Omada Health's score of 0.44 indicating that Viemed Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Viemed Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Omada Health	1 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

74.2% of Viemed Healthcare shares are held by institutional investors. 20.6% of Viemed Healthcare shares are held by company insiders. Comparatively, 6.4% of Omada Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Viemed Healthcare has a beta of 1.04, meaning that its stock price is 4% more volatile than the broader market. Comparatively, Omada Health has a beta of 2.03, meaning that its stock price is 103% more volatile than the broader market.

Viemed Healthcare has higher revenue and earnings than Omada Health. Viemed Healthcare is trading at a lower price-to-earnings ratio than Omada Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viemed Healthcare	$270.28M	1.37	$14.93M	$0.36	26.92
Omada Health	$260.21M	4.29	-$12.78M	$0.05	364.40

Summary

Viemed Healthcare beats Omada Health on 9 of the 17 factors compared between the two stocks.

How does Viemed Healthcare compare to InnovAge?

Viemed Healthcare (NASDAQ:VMD) and InnovAge (NASDAQ:INNV) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, media sentiment, institutional ownership and valuation.

In the previous week, InnovAge had 3 more articles in the media than Viemed Healthcare. MarketBeat recorded 5 mentions for InnovAge and 2 mentions for Viemed Healthcare. InnovAge's average media sentiment score of 0.97 beat Viemed Healthcare's score of 0.61 indicating that InnovAge is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Viemed Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InnovAge	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

74.2% of Viemed Healthcare shares are owned by institutional investors. Comparatively, 12.3% of InnovAge shares are owned by institutional investors. 20.6% of Viemed Healthcare shares are owned by company insiders. Comparatively, 1.0% of InnovAge shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Viemed Healthcare presently has a consensus price target of $14.00, indicating a potential upside of 44.48%. InnovAge has a consensus price target of $10.50, indicating a potential upside of 15.64%. Given Viemed Healthcare's stronger consensus rating and higher probable upside, research analysts plainly believe Viemed Healthcare is more favorable than InnovAge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viemed Healthcare	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25
InnovAge	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75

Viemed Healthcare has higher earnings, but lower revenue than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viemed Healthcare	$270.28M	1.37	$14.93M	$0.36	26.92
InnovAge	$989.71M	1.25	-$2.54M	-$0.02	N/A

Viemed Healthcare has a beta of 1.04, suggesting that its stock price is 4% more volatile than the broader market. Comparatively, InnovAge has a beta of 0.15, suggesting that its stock price is 85% less volatile than the broader market.

Viemed Healthcare has a net margin of 4.81% compared to InnovAge's net margin of -0.26%. Viemed Healthcare's return on equity of 10.16% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Viemed Healthcare	4.81%	10.16%	7.22%
InnovAge	-0.26%	-1.03%	-0.47%

Summary

Viemed Healthcare beats InnovAge on 11 of the 14 factors compared between the two stocks.

Get Viemed Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

VMD vs. The Competition

Export

Metric	Viemed Healthcare	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$366.03M	$10.03B	$7.19B	$13.18B
Dividend Yield	N/A	2.61%	2.52%	19.59%
P/E Ratio	26.69	30.42	223.62	21.16
Price / Sales	1.37	4.67	547.34	66.59
Price / Cash	8.35	115.88	76.68	52.75
Price / Book	2.56	5.14	10.22	5.92
Net Income	$14.93M	$315.68M	$3.50B	$380.90M
7 Day Performance	2.98%	0.00%	-3.50%	-3.90%
1 Month Performance	10.74%	-4.32%	-7.78%	-6.42%
1 Year Performance	40.64%	9.31%	0.79%	-6.02%

Viemed Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
VMD Viemed Healthcare	3.7065 of 5 stars	$9.69 +0.8%	$14.00 +44.5%	+40.6%	$366.03M	$270.28M	26.69	1,382
AGL Agilon Health	2.1373 of 5 stars	$86.03 +0.6%	$102.25 +18.9%	+283.0%	$1.44B	$5.93B	N/A	856	Gap Down
PNTG The Pennant Group	2.8825 of 5 stars	$40.15 -0.9%	$42.00 +4.6%	+69.6%	$1.42B	$947.71M	36.84	9,700
AMN AMN Healthcare Services	1.1903 of 5 stars	$36.59 +0.8%	$36.50 -0.2%	+83.2%	$1.41B	$2.73B	13.65	2,664
OMDA Omada Health	3.8442 of 5 stars	$18.30 -16.3%	$26.67 +45.7%	-25.7%	$1.34B	$260.21M	273.38	946	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:VMD) was last updated on 10/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Viemed Healthcare (VMD) Competitors

VMD vs. AGL, PNTG, AMN, OMDA, and INNV

How does Viemed Healthcare compare to Agilon Health?

Summary

How does Viemed Healthcare compare to The Pennant Group?

Summary

How does Viemed Healthcare compare to AMN Healthcare Services?

Summary

How does Viemed Healthcare compare to Omada Health?

Summary

How does Viemed Healthcare compare to InnovAge?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VMD vs. The Competition

Viemed Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Viemed Healthcare (VMD) Competitors

VMD vs. AGL, PNTG, AMN, OMDA, and INNV

How does Viemed Healthcare compare to Agilon Health?

Which has stronger valuation and earnings, VMD or AGL?

Does the media favor VMD or AGL?

Do institutionals and insiders have more ownership in VMD or AGL?

Which has more volatility & risk, VMD or AGL?

Do analysts recommend VMD or AGL?

Is VMD or AGL more profitable?

Summary

How does Viemed Healthcare compare to The Pennant Group?

Do analysts prefer PNTG or VMD?

Is PNTG or VMD more profitable?

Do insiders and institutionals hold more shares of PNTG or VMD?

Does the media refer more to PNTG or VMD?

Which has more volatility & risk, PNTG or VMD?

Which has higher valuation and earnings, PNTG or VMD?

Summary

How does Viemed Healthcare compare to AMN Healthcare Services?

Does the media prefer AMN or VMD?

Do analysts rate AMN or VMD?

Do institutionals and insiders hold more shares of AMN or VMD?

Which has more volatility and risk, AMN or VMD?

Is AMN or VMD more profitable?

Which has stronger valuation & earnings, AMN or VMD?

Summary

How does Viemed Healthcare compare to Omada Health?

Is VMD or OMDA more profitable?

Do analysts recommend VMD or OMDA?

Does the media prefer VMD or OMDA?

Do institutionals & insiders hold more shares of VMD or OMDA?

Which has more volatility and risk, VMD or OMDA?

Which has higher valuation & earnings, VMD or OMDA?

Summary

How does Viemed Healthcare compare to InnovAge?

Does the media favor VMD or INNV?

Do insiders & institutionals believe in VMD or INNV?

Do analysts rate VMD or INNV?

Which has stronger earnings & valuation, VMD or INNV?

Which has more risk and volatility, VMD or INNV?

Is VMD or INNV more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VMD vs. The Competition

Viemed Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools